An Dose Escalation Study of Treatment With BIBF 1120 in Patients With Advanced Solid Tumours
Clinical trial NCT02182206 · COMPLETED
Trial details
- NCT number
- NCT02182206
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2003-06-01
- Primary completion
- 2005-06-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.